Pfizer CEO stands by company’s performance in response to Starboard activist critique

Pfizer CEO stands by company’s performance in response to Starboard activist critique

Pfizer’s CEO Albert Bourla responded to activist investor Starboard Value’s criticisms on Tuesday, as the drugmaker increased its revenue projections for 2024. Bourla defended Pfizer’s management and strategies, stating that the company was already on track for a successful turnaround. He expressed willingness to engage with shareholders, including Starboard, to consider ideas that would benefit … Read more

Starboard urges Pfizer board to ‘ensure management responsibility’

Starboard urges Pfizer board to ‘ensure management responsibility’

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Activist investor Starboard Value has called on Pfizer’s leadership to take action and hold management accountable for its underperforming performance. This comes as Starboard publicly discussed its plans for the pharmaceutical company after acquiring a … Read more